Clinical Experience and Critical Evaluation of the Role of Everolimus in Advanced Renal Cell Carcinoma

Research and Reports in Urology - New Zealand
doi 10.2147/rru.s13283
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Informa UK Limited

Related search

Re: Nivolumab Versus Everolimus in Advanced Renal-Cell Carcinoma

European Urology
Urology
2016English

Clinical Experience With Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2015English

The Bevacizumab Experience in Advanced Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2010English

Everolimus in Metastatic Renal Cell Carcinoma : Preliminary Experience From Chang Gung Memorial Hospital

Biomedical Journal
Medicine
2012English

Everolimus &Ndash; A New Approach in the Treatment of Renal Cell Carcinoma

Cancer Management and Research
Oncology
2010English

Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?

Clinical Medicine Insights: Oncology
Oncology
2011English

Nivolumab in the Treatment of Advanced Renal Cell Carcinoma

Oncology in Clinical Practice
Oncology
2019English

Rationale for Targeted Therapies and Potential Role of Pazopanib in Advanced Renal Cell Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2010English

Outcomes Based on Age in the Phase III METEOR Trial of Cabozantinib Versus Everolimus in Patients With Advanced Renal Cell Carcinoma

European Journal of Cancer
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy